Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates | ![]() Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. | EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals. | ||
Founding Date | Founding Date 1999 | Founding Date 1985 | Founding Date 2010 | Founding Date 1935 | Founding Date 1964 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Hayward, US HQ Zhunan Township, TW Chalfont, US Philadelphia, US Fort Washington, US | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations BR HQ |
Employees | Employees 1,495 | Employees 9,067 | Employees 14,858 | Employees 27,764 | Employees 12,7441% increase |
Valuation ($) | Valuation ($) 1.4 b | Valuation ($) 4.2 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $775.8m (FY, 2017) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) ₹73.4b (FY, 2026) | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) N/A |
Cost of goods | Cost of goods $535.1m (FY, 2017) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods ₹19.8b (FY, 2026) | Cost of goods ₹95.5b (FY, 2026) | Cost of goods N/A |
Gross profit | Gross profit $240.7m (FY, 2017) | Gross profit ¥7.8b (FY, 2025) | Gross profit ₹54.1b (FY, 2026) | Gross profit ₹195b (FY, 2026) | Gross profit N/A |
Net income | Net income ($469.3m) (FY, 2017) | Net income ¥2.4b (FY, 2025) | Net income ₹6.7b (FY, 2026) | Net income ₹38.7b (FY, 2026) | Net income N/A |
Operating ⚠ | |||||
Products | Products N/A | Products N/A | Products 145 (FY, 2024) | Products 1.5 k (FY, 2024) | Products N/A |
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyAlembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View company
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyEMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
View company